MedTech Dive February 2, 2024
Kevin Hykes joins the company as it looks to grow the market for its device to improve heart failure symptoms.
Name: Kevin Hykes
Current role: CEO and president of CVRx
Previous role: CEO and president of Augmedics
Kevin Hykes will become CEO of CVRx beginning Feb. 12, the company announced Wednesday. The Minneapolis-based company makes Barostim, a device that uses neuromodulation to improve the symptoms of heart failure.
Hykes is familiar with the company, having served on its board since 2022. He will take the helm from current CEO Nadim Yared, who announced plans to retire last month once the company found a successor. Yared will give up a board seat but will remain with the company as a...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices